James P. Wilson

Replication of the Weber Effect Using Postmarketing Adverse Event Reports Voluntarily Submitted to the United States Food and Drug Administration

Nicole R. Hartnell, James P. Wilson · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2004 · 163 citations

Pharmacy, Pharmacology, Clinical Pharmacology +16

Temporal Relationship between Use of NSAIDs, Including Selective COX-2 Inhibitors, and Cardiovascular Risk

Stephen P. Motsko, Karen L. Rascati, Anthony J. Busti et al. · Drug Safety · 2006 · 120 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Nifedipine: Kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration

C. H. Kleinbloesem, J. Van Harten, James P. Wilson et al. · Clinical Pharmacology & Therapeutics · 1986 · 108 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Examination of pharmacists’ intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior

Paul Gavaza, Carolyn M. Brown, Kenneth A. Lawson et al. · Research in Social and Administrative Pharmacy · 2010 · 70 citations

Pharmacy, Pharmacy Practice, Regulatory Pharmacy +11

Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker

Gary J. Okano, Karen L. Rascati, James P. Wilson et al. · Clinical Therapeutics · 1997 · 53 citations

Medicine, Cardiology, Internal Medicine +10